194 related articles for article (PubMed ID: 17300357)
21. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.
Lipton RB; Cutrer FM; Goadsby PJ; Ferrari MD; Dodick DW; McCrory D; Liberman JN; Williams P
Curr Med Res Opin; 2005 Mar; 21(3):413-24. PubMed ID: 15811210
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
25. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
[TBL] [Abstract][Full Text] [Related]
27. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
28. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
Cutrer FM; Goadsby PJ; Ferrari MD; Lipton RB; Dodick DW; McCrory D; Williams P
Clin Ther; 2004 Sep; 26(9):1533-45. PubMed ID: 15531016
[TBL] [Abstract][Full Text] [Related]
29. Treatment-emergent CNS symptoms following triptan therapy are part of the attack.
Goadsby PJ; Dodick DW; Almas M; Diener HC; Tfelt-Hansen P; Lipton RB; Parsons B
Cephalalgia; 2007 Mar; 27(3):254-62. PubMed ID: 17381558
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
Cady R; Martin V; Mauskop A; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2006 Jun; 46(6):914-24. PubMed ID: 16732837
[TBL] [Abstract][Full Text] [Related]
31. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
[TBL] [Abstract][Full Text] [Related]
32. Eletriptan.
Sandrini G; Perrotta A; Tassorelli C; Nappi G
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
[TBL] [Abstract][Full Text] [Related]
33. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
34. Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
Almas M; Tepper SJ; Landy S; Schweizer E; Ramos E
Cephalalgia; 2014 Feb; 34(2):126-35. PubMed ID: 23946318
[TBL] [Abstract][Full Text] [Related]
35. Eletriptan in migraine.
Diener HC
Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
[TBL] [Abstract][Full Text] [Related]
36. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
37. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.
Martin VT; Loder E; Taylor K; Almas M; Hilliard B
Cephalalgia; 2005 Sep; 25(9):726-34. PubMed ID: 16109055
[TBL] [Abstract][Full Text] [Related]
38. Eletriptan for acute migraine.
Smith LA; Oldman AD; McQuay HJ; Moore RA
Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
[TBL] [Abstract][Full Text] [Related]
39. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
[TBL] [Abstract][Full Text] [Related]
40. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
Cheung R; Krishnaswami S; Kowalski K
Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]